ข่าวธุรกิจในเอเชียตะวันออกเฉียงใต้

ข่าวธุรกิจในประเทศไทยและเอเชียตะวันออกเฉียงใต้ | Business News in Thailand & South East Asia

ป้ายกำกับ: clinical

Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

Foster City, CA, Shanghai […]

2021-11-22

Eisai Presents New Analysis of Lecanemab Clinical Efficacy Results from Phase 2b Study at Clinical Trials On Alzheimer’s Disease (CTAD) Conference

TOKYO and CAMBRIDGE, Mass […]

2021-11-12

Eisai: Introduction of Plasma-based Biomarker Screening to Facilitate Identification of Subjects for Phase 3 Ahead 3-45 Trial Presented at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

TOKYO and CAMBRIDGE, Mass […]

2021-11-12

Eisai: DIAN-TU Selects Lecanemab as Background Anti-Amyloid Therapy in Clinical Trial Evaluating Investigational Therapy Targeting Tau for Dominantly Inherited Alzheimer’s Disease

TOKYO, Nov 9, 2021 &#8211 […]

2021-11-09

Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain

ADELAIDE, AUS, Oct 19, 20 […]

2021-10-19

Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies – OCT Webinar

ADELAIDE, AUS, Oct 19, 20 […]

2021-10-19

CerbACT Asia Holds Ribbon Cutting to Celebrate New Immuno-oncology Centre of Excellence

HONG KONG, Oct 7, 2021 &# […]

2021-10-07

SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases

HONG KONG, Sep 17, 2021 & […]

2021-09-17

Kintor Pharma Announces 2021 Interim Results

SUZHOU, CHINA, Aug 30, 20 […]

2021-08-30

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership

ADELAIDE, AUS, Aug 10, 20 […]

2021-08-10